 |
|
|
| |
Efficacy and Safety of Bulevirtide 2 mg or 10 mg for 96 Weeks in Chronic Hepatitis Delta, Including in 2 Patients With HIV/Hepatitis B Virus/Hepatitis Delta Virus
|
| |
| |
CROI 2024 March 3-6 Denver
Heiner Wedemeyer1, Soo Aleman2, Maurizia Brunetto3,4, David L Wyles5, Viacheslav Morozov6, Vladimir Chulanov7, Ben L Da8, Renee-Claude Mercier8, Grace M Chee8, Mingyang Li8, Pietro Lampertico9,10
|
| |
|
|
|
|
|
